Steris PLC stock slips 1.14% but outperforms some rivals
Updated
Updated · MarketWatch · May 1
Steris PLC stock slips 1.14% but outperforms some rivals
8 articles · Updated · MarketWatch · May 1
The shares closed at $214.40 as the S&P 500 rose 0.29% to 7,230.12 and the Dow Jones Industrial Average fell 0.31% to 49,499.27.
Steris ended 20.43% below its 52-week high of $269.44 reached on 16 January, while Thermo Fisher and Danaher fell more than 2% and Becton Dickinson edged up 0.18%.
Trading volume was 678,839 shares, 117,851 below the 50-day average of 796,690, indicating lighter-than-usual activity during a mixed broader market session.
With analysts predicting a 28% upside, what is holding Steris's stock price so far below its 52-week high?
Amidst competitor megadeals, is Steris positioned for a major acquisition or at risk of becoming a target itself?
Can Steris navigate the FDA’s strict new quality rules while capitalizing on the EPA's relaxed emission standards for growth?